Anke Mütherig
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Chronic Lymphocytic Leukemia Research
- Mesenchymal stem cell research
Papers in
-
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 2
-
- Pain Management and Opioid Use 2
- Co-authors
- Gerhard Behre (2 shared papers)Sebastian Theurich (2 shared papers)Maximilian Christopeit (2 shared papers)Wilfried Grothe (2 shared papers)Lutz Peter Mueller (1 shared paper)Johannes Schetelig (1 shared paper)Thomas E. Weber (1 shared paper)Jan Moritz Middeke (2 shared papers)
- Journals
- Blood (2 papers)Bone Marrow Transplantation (2 papers)Scientific Reports (1 paper)The Lancet Oncology (1 paper)European Journal Of Haematology (1 paper)
- Partner nations
- Germany
In The Last Decade
Anke Mütherig
11 papers receiving 362 citations
Anke Mütherig's Hit Papers
Peers
Comparison fields: 5 of 39
- Hematology 298
- Genetics 26
- Toxicology 4
- Infectious Diseases 9
- Public Health, Environmental and Occupational Health 14
Countries citing papers authored by Anke Mütherig
This map shows the geographic impact of Anke Mütherig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Mütherig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Mütherig more than expected).
Fields of papers citing papers by Anke Mütherig
This network shows the impact of papers produced by Anke Mütherig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Mütherig. The network helps show where Anke Mütherig may publish in the future.
Co-authors
The 25 scholars most cited alongside Anke Mütherig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial Hit paper breakdown → | 2018 | 282 |
| 2 | 2007 | 37 | |
| 3 | 2016 | 22 | |
| 4 | 2007 | 15 | |
| 5 | 2017 | 6 | |
| 6 | 2019 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2025 | 1 |
About Anke Mütherig
Anke Mütherig is a scholar working on Hematology, Anesthesiology and Pain Medicine, Genetics, Health Information Management and Oncology, having authored 12 papers that have together received 372 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Electronic Health Records Systems (2 papers), Cancer survivorship and care (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Pain Management and Opioid Use (2 papers), Mesenchymal stem cell research (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Parvovirus B19 Infection Studies (1 paper). The work is most often cited by research in Hematology (298 citations), Genetics (26 citations), Toxicology (4 citations), Infectious Diseases (9 citations) and Public Health, Environmental and Occupational Health (14 citations). Anke Mütherig has collaborated with scholars based in Germany. Frequent co-authors include Gerhard Behre, Sebastian Theurich, Maximilian Christopeit, Wilfried Grothe, Lutz Peter Mueller, Johannes Schetelig, Thomas E. Weber, Jan Moritz Middeke, Uta Oelschlägel and Malte v. Bonin. Their work appears in journals such as Blood, Bone Marrow Transplantation, Scientific Reports, The Lancet Oncology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.